[
1. Dahan K. Membranous nephropathy: diagnosis, new insights in pathophysiology, and therapeutic approach. Rev Med Interne. 2016;37(10):674.10.1016/j.revmed.2016.02.00327236434
]Search in Google Scholar
[
2. Ponticelli C, Passerini P. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy. J Nephrol. 2010;23(2):156-63.
]Search in Google Scholar
[
3. Ronco P, Debiec H. Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient. Biologie aujourd’hui. 2013;207(4):249-59.10.1051/jbio/201302524594573
]Search in Google Scholar
[
4. Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, et al. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol. 2012;23(12):1949-54.10.1681/ASN.2012060577350737123123401
]Search in Google Scholar
[
5. Filinte D, Arıkan H, Koç M, Kaya H, Özener IC, Akbaş G. The intensity of PLA2R and C4d immunoexpression in primary membranous nephropathy. South Clin Ist Euras. 2020;31(2).10.14744/scie.2019.16056
]Search in Google Scholar
[
6. Debiec H, Ronco P. Immunopathogenesis of membranous nephropathy: an update. Sem Immunopathol. 2014;36(4):381-97.10.1007/s00281-014-0423-y24715030
]Search in Google Scholar
[
7. Torbati PM, Haleh Tavakolian H. Diagostic Accuracy of C4d-IHC in Diagnosis of Membranous Glomerulonephritis. Iran J Kidney Dis. 2020;14(1):20.
]Search in Google Scholar
[
8. Kościelska-Kasprzak K, Bartoszek D, Myszka M, Żabińska M, Klinger M. The complement cascade and renal disease. Arch Immunol Ther Exp. 2014;62(1):47-57.10.1007/s00005-013-0254-x389835324030732
]Search in Google Scholar
[
9. Ma H, Sandor DG, Beck LH. The role of complement in membranous nephropathy. Sem Nephrol. 2013;33(6):531-42.10.1016/j.semnephrol.2013.08.004427499624161038
]Search in Google Scholar
[
10. Beck LH, Salant DJ. Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 2010;77(9):765-70.10.1038/ki.2010.3420182413
]Search in Google Scholar
[
11. Cohen D, Colvin RB., Daha MR, Drachenberg CB. Haas M, Nickeleit V, et al. Pros and cons for C4d as a biomarker. Kidney Int. 2012;81(7):628-39.10.1038/ki.2011.497377110422297669
]Search in Google Scholar
[
12. Espinosa M, Ortega R, Sanchez M, Segarra A, Salcedo MT, Gonzalez F, et al. Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2014;9(5):897-904.10.2215/CJN.09710913401145524578331
]Search in Google Scholar
[
13. Larsen C P, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26(5):709-15.10.1038/modpathol.2012.20723196797
]Search in Google Scholar
[
14. Stangou MJ, Marinaki S, Papachristou E, Liapis G, Pateinakis P, Gakiopoulou H, et al. Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients. Histopathology. 2019;75(5):660-71.10.1111/his.13955685698331318463
]Search in Google Scholar
[
15. McClish DK. Analyzing a portion of the ROC curve. Med Decis Making. 1989;9(3):190-5.10.1177/0272989X89009003072668680
]Search in Google Scholar
[
16. Glassock RJ. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am J Kidney Dis. 2010;56(1):157-67.10.1053/j.ajkd.2010.01.00820378220
]Search in Google Scholar
[
17. Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33(6):479-92.10.1016/j.semnephrol.2013.08.001382002924161035
]Search in Google Scholar
[
18. Sheerm NS, Risley P, Abe K, Tang Z, Wong W, Lin T, et al. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J. 2008;22(4):1065-72.10.1096/fj.07-8719com18039928
]Search in Google Scholar
[
19. Colvin RB. Pathology of chronic humoral rejection. Contrib Nephrol. 2009;162:75-86.10.1159/00017081419001815
]Search in Google Scholar
[
20. Einecke GB, Sis J, Reeve M, Mengel PM, Campbell LG, Hidalgo B, et al. Halloran antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant. 2009;9(11):2520-31.10.1111/j.1600-6143.2009.02799.x19843030
]Search in Google Scholar
[
21. Murata K, Baldwin WM. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transpl Rev. 2009;23(3):139-50.10.1016/j.trre.2009.02.005279736819362461
]Search in Google Scholar
[
22. Zwirner J, Felber E, Herzog V, Riethmüller G, Feucht HE. Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int. 1989;36(6):1069-77.10.1038/ki.1989.3022689750
]Search in Google Scholar
[
23. Zwirner J, Felber E, Burger R, Bitter-Suermann D, Riethmüller G, Feucht HE. Classical pathway of complement activation in mammalian kidneys. Immunology. 1993;80(2):162.
]Search in Google Scholar
[
24. Beck Jr LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. Salant M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med. 2009;361(1):11-21.10.1056/NEJMoa0810457276208319571279
]Search in Google Scholar
[
25. Couser WG. Primary membranous nephropathy. CJASN. 2017;12(6):983-97.10.2215/CJN.11761116546071628550082
]Search in Google Scholar
[
26. Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction. Nephrol Dial Transplant. 2008;23(5):1735-41.10.1093/ndt/gfm84318065805
]Search in Google Scholar
[
27. Val-Bernal J, Fernando M, Garijo F, Val D, Rodrigo E, Arias M. C4d immunohistochemical staining is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis. Histol Histopathol. 2011;26(11):1391-7.
]Search in Google Scholar
[
28. Espinosa-Hernández M, Ortega-Salas R, López-Andreu M, Gómez-Carrasco JM, Pérez-Sáez MJ, Pérez-Seoane C, et al. C4d as a diagnostic tool in membranous nephropathy. Nefrología (English Edition). 2012;32(4):536.
]Search in Google Scholar
[
29. Bichuette CF, Aparecida da Silva C, Rodrigues Helmo F, Reis Machado J, Antônia dos Reis M. Complement System and C4d expression in cases of Membranous nephropathy. Braz J Nephrology. 2017;39(4):370-5.
]Search in Google Scholar
[
30. Song YS, Min KW, Kim JH, Kim GH, Park MH. Differential diagnosis of lupus and primary membranous nephropathies by IgG subclass analysis. Clin J Am Soc Nephrol. 2012;7(12):1947-55.10.2215/CJN.04800511351374923024158
]Search in Google Scholar
[
31. Obana M, Nakanishi K, Sako M, Yata N, Nozu K, Tanaka R, et al. Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis. Clin J Am Soc Nephrol. 2006;1(4):723-9.10.2215/CJN.0121100517699279
]Search in Google Scholar
[
32. Segawa Y, Hisano S, Matsushita M, Fujita T, Hirose S, Takeshita M, et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediat Nephrol. 2010;25(6):1091-9.10.1007/s00467-009-1439-820151159
]Search in Google Scholar
[
33. Bally S, Debiec H, Ponard D, Dijoud F, Rendu J, Fauré J, et al. Phospholipase A2 receptor–related membranous nephropathy and mannan-binding lectin deficiency. J Am Soc Nephrol. 2016;27(12):3539-44.10.1681/ASN.2015101155511848527153925
]Search in Google Scholar
[
34. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005;16(5):1214-22.10.1681/ASN.200501009615800113
]Search in Google Scholar
[
35. Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropat hy –a modern v iew. Clin J Am Soc Nephrol. 2014;9(3):609-16.10.2215/CJN.04160413394475623813556
]Search in Google Scholar
[
36. Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A, et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol. 2012;7(9):1394-400.10.2215/CJN.02170312343094622773590
]Search in Google Scholar
[
37. mmunohistochemistry in membranous nephropathy. J Lab Physicians. 2014;6(2):76.10.4103/0974-2727.141500419636725328330
]Search in Google Scholar
[
38. Espinosa-Hernández M, Ortega-Salas R, López-Andreu M, Gómez-Carrasco JM, Pérez-Sáez MJ, Pérez-Seoane C, Aljama-García P. C4d as a diagnostic tool in membranous nephropathy. Nefrología (English Edition). 2012;32(3):295-9.
]Search in Google Scholar
[
39. Lim BJ, Kim MS, Kim YS, Kim SI, Jeong HI. C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury. Transplant Proc. 2012;44(3):619-20.10.1016/j.transproceed.2011.12.05222483452
]Search in Google Scholar